关于 "LPL Receptor" 的结果17+ 个结果
筛选:Endocrinology and Hormones×
- Opioid receptor modulator 1CAS: 77514-44-4
Opioidreceptormodulator1是一种阿片受体(opioidreceptor)调节剂，详细信息请参考专利文献WO2014072809A2中EXAMPLE7中的化合物RA11。
- Androgen receptor-IN-2CAS: 2416716-62-4
Androgen receptor-IN-2 是一种有效的、具有口服活性的 Androgen Receptor 抑制剂。Androgen receptor-IN-2 对前列腺癌具有抗肿瘤活性。
- Androgen receptor-IN-6CAS: 3016437-05-8
Androgen receptor-IN-6（化合物16）是一种口服雄激素受体（雄激素受体）强效抑制剂（体外IC50=0.12μM），靶向无序的N-末端结构域（NTD）。
- Thyroid Hormone Receptor Antagonist (1-850)CAS: 251310-57-3
Blocks T3 binding to the thyroid hormone receptor
- Fsh receptor-binding inhibitor fragment(bi-10)CAS: 163973-98-6
Fsh receptor-binding inhibitor fragment(bi-10)是一种强效的FSH拮抗剂。
- RaloxifeneCAS: 84449-90-1
Raloxifene (Keoxifene, Pharoxifene, LY-139481, LY-156758, CCRIS-7129) is a second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women.
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC31250 | Opioid receptor modulator 1 | 77514-44-4 | Opioid Receptor | ||
Opioidreceptormodulator1是一种阿片受体(opioidreceptor)调节剂，详细信息请参考专利文献WO2014072809A2中EXAMPLE7中的化合物RA11。 | |||||
| GC67698 | Androgen receptor-IN-2 | 2416716-62-4 | Androgen Receptor | ||
Androgen receptor-IN-2 是一种有效的、具有口服活性的 Androgen Receptor 抑制剂。Androgen receptor-IN-2 对前列腺癌具有抗肿瘤活性。 | |||||
| GC73577 | Androgen receptor-IN-6 | 3016437-05-8 | Androgen Receptor | ||
Androgen receptor-IN-6（化合物16）是一种口服雄激素受体（雄激素受体）强效抑制剂（体外IC50=0.12μM），靶向无序的N-末端结构域（NTD）。 | |||||
| GC10413 | Thyroid Hormone Receptor Antagonist (1-850) | 251310-57-3 | Thyroid hormone Receptor | ||
Blocks T3 binding to the thyroid hormone receptor | |||||
| GC72225 | Fsh receptor-binding inhibitor fragment(bi-10) | 163973-98-6 | GnRH | ||
Fsh receptor-binding inhibitor fragment(bi-10)是一种强效的FSH拮抗剂。 | |||||
| GC17688 | Diarylpropionitrile(DPN) | 1428-67-7 | Estrogen Receptor/ERR | ||
An estrogen receptor β agonist | |||||
| GC13688 | Naltrindole hydrochloride | 111469-81-9 | Opioid Receptor | ||
A potent, selective δ-opioid receptor antagonist | |||||
| GC16292 | Equol | 94105-90-5 | Endogenous Metabolite | ||
An estrogen receptor agonist | |||||
| GC44999 | Tauro-α-muricholic Acid (sodium salt) | 2260905-08-4 | FXR & LXR | ||
An FXR receptor antagonist | |||||
| GC13350 | Raloxifene HCl | 82640-04-8 | Autophagy | ||
A selective estrogen receptor modulator | |||||
| GC11425 | Lasofoxifene (tartrate) | 190791-29-8 | Estrogen Receptor/ERR | ||
A selective estrogen receptor modulator | |||||
| GC14221 | HE-3235 | 183387-50-0 | Androgen Receptor | ||
Androgen receptor antagonist | |||||
| GC12445 | TFM-4AS-1 | 188589-61-9 | Androgen Receptor | ||
androgen receptor modulator | |||||
| GC25832 | Raloxifene | 84449-90-1 | Estrogen/progestogen Receptor | ||
Raloxifene (Keoxifene, Pharoxifene, LY-139481, LY-156758, CCRIS-7129) is a second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. | |||||
| GC13971 | Cyproterone Acetate | 427-51-0 | Androgen Receptor | ||
An androgen receptor antagonist | |||||
| GC10702 | Trimebutine | 39133-31-8 | Opioid Receptor | ||
An opioid receptor agonist | |||||
| GC11781 | Medroxyprogesterone | 520-85-4 | Estrogen/progestogen Receptor | ||
A progesterone receptor agonist | |||||